ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,602.59
0.62%
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs Yen
157.405
0.00%
Brent Oil
82.275
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. ヨーロッパ
  5. EU
  6. PHAXIAM Therapeutics SA (PHXM)

  7. PHAXIAM Therapeutics SA (PHXM) ニュース

PHXM

PHAXIAM Therapeutics (PHXM)

PHAXIAM Therapeutics SA
から:
次の項目別のソート:
 Showing the most relevant articles for your search:EU:PHXM
日付受信時刻ニュースソース見出しコード企業名
2024/06/1215 : 00GlobeNewswire Inc.Lancement d'une augmentation de capital avec maintien du DPS d’un montant d’environ 10 M€, susceptible d’être porté à environ 11,5 M€ en cas d’exercice intégral de la clause d'extensionEU:PHXMPHAXIAM Therapeutics SA
2024/06/0800 : 45GlobeNewswire Inc.PHAXIAM annonce les modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 28 juin 2024EU:PHXMPHAXIAM Therapeutics SA
2024/06/0800 : 45GlobeNewswire Inc.PHAXIAM announces the availability of the preparatory documents for the Combined General Meeting of 28 June 2024EU:PHXMPHAXIAM Therapeutics SA
2024/06/0601 : 00GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 mai 2024EU:PHXMPHAXIAM Therapeutics SA
2024/06/0601 : 00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – May 31, 2024EU:PHXMPHAXIAM Therapeutics SA
2024/05/1600 : 45GlobeNewswire Inc.PHAXIAM Therapeutics fait le point sur ses activités et publie l’information financière du premier trimestre 2024EU:PHXMPHAXIAM Therapeutics SA
2024/05/1600 : 45GlobeNewswire Inc.PHAXIAM provides Business and Financial Update for the First Quarter of 2024EU:PHXMPHAXIAM Therapeutics SA
2024/05/0401 : 05GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2024EU:PHXMPHAXIAM Therapeutics SA
2024/05/0401 : 05GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2024EU:PHXMPHAXIAM Therapeutics SA
2024/04/1514 : 30GlobeNewswire Inc.PHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureusEU:PHXMPHAXIAM Therapeutics SA
2024/04/1514 : 30GlobeNewswire Inc.PHAXIAM Therapeutics annonce le recrutement du premier patient dans l’étude de phase 1 dans l’endocardite infectieuse causée par le Staphylococcus aureusEU:PHXMPHAXIAM Therapeutics SA
2024/04/1001 : 00GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 mars 2024EU:PHXMPHAXIAM Therapeutics SA
2024/04/1001 : 00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital – March 29, 2024EU:PHXMPHAXIAM Therapeutics SA
2024/04/0601 : 00GlobeNewswire Inc.PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)EU:PHXMPHAXIAM Therapeutics SA
2024/04/0601 : 00GlobeNewswire Inc.PHAXIAM Therapeutics annonce le dépôt de son Document d’Enregistrement Universel (URD) 2023EU:PHXMPHAXIAM Therapeutics SA
2024/03/1115 : 00GlobeNewswire Inc.PHAXIAM Therapeutics annonce la réalisation du retrait volontaire de ses « American Depository Shares » du Nasdaq Stock MarketEU:PHXMPHAXIAM Therapeutics SA
2024/03/1115 : 00GlobeNewswire Inc.PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock MarketEU:PHXMPHAXIAM Therapeutics SA
2024/03/1115 : 00GlobeNewswire Inc.PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock MarketEU:PHXMPHAXIAM Therapeutics SA
2024/03/0602 : 00GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 février 2024EU:PHXMPHAXIAM Therapeutics SA
2024/03/0602 : 00GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital - February 29, 2024EU:PHXMPHAXIAM Therapeutics SA
2024/02/2106 : 05GlobeNewswire Inc.PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital MarketEU:PHXMPHAXIAM Therapeutics SA
2024/02/2106 : 05GlobeNewswire Inc.PHAXIAM Therapeutics annonce son intention de procéder au retrait volontaire de ses « American Depositary Shares » du Nasdaq Capital MarketEU:PHXMPHAXIAM Therapeutics SA
2024/02/2106 : 05GlobeNewswire Inc.PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital MarketEU:PHXMPHAXIAM Therapeutics SA
2024/02/0706 : 05GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital - January 31, 2024EU:PHXMPHAXIAM Therapeutics SA
2024/02/0706 : 05GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2024EU:PHXMPHAXIAM Therapeutics SA
2024/01/1906 : 05GlobeNewswire Inc.PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024EU:PHXMPHAXIAM Therapeutics SA
2024/01/1906 : 05GlobeNewswire Inc.PHAXIAM Therapeutics annonce son niveau de trésorerie à fin 2023 et son calendrier financier 2024EU:PHXMPHAXIAM Therapeutics SA
2024/01/1906 : 05GlobeNewswire Inc.PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024EU:PHXMPHAXIAM Therapeutics SA
2024/01/0406 : 05GlobeNewswire Inc.Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 décembre 2023EU:PHXMPHAXIAM Therapeutics SA
2024/01/0406 : 05GlobeNewswire Inc.Monthly information related to total number of voting rights and shares composing the share capital - December 31, 2023EU:PHXMPHAXIAM Therapeutics SA
 Showing the most relevant articles for your search:EU:PHXM

最近閲覧した銘柄

NYSE
MRK
Merck
CCOM
US500
US 500
PM
XAUUSD
Gold vs US Dollar
USI
USTECH100
US Tech 100
NYSE
DIS
Walt Disney
FX
USDGBP
US Dollar vs Sterling
NYSE
VZ
Verizon Communications
NYSE
BAC
Bank of America
USOTC
BASFY
BASF (QX)
NYSE
CVX
Chevron
NASDAQ
AAPL
Apple
AMEX
XLF
Financial Select Sector
COIN
SOLUSD
Solana
FX
USDEUR
US Dollar vs Euro
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有